N-Acetyl-GED-0507-34-Levo GEL 5%
Sponsors
PPM Services S.A.
Conditions
Acne VulgarisAcne vulgarisacne vulgaris
Phase 3
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)
RecruitingCTIS2023-510339-12-00
Start: 2024-11-11Target: 300Updated: 2026-01-26
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)
RecruitingCTIS2023-510341-19-00
Start: 2024-11-14Target: 310Updated: 2025-11-10
A long-term safety and efficacy study of N-Acetyl-GED-0507-34-LEVO gel 5%, in subjects with acne vulgaris (GEDACNE-LT)
RecruitingCTIS2023-510342-24-00
Start: 2024-11-11Target: 320Updated: 2025-11-12
A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)
Active, not recruitingNCT07389109
Start: 2024-12-05End: 2026-12-01Target: 400Updated: 2026-09-15